<SEC-DOCUMENT>0001485003-15-000019-index.html : 20151110
<SEC-HEADER>0001485003-15-000019.hdr.sgml : 20151110
<ACCEPTANCE-DATETIME>20151106161223
ACCESSION NUMBER:		0001485003-15-000019
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20150930
FILED AS OF DATE:		20151106
DATE AS OF CHANGE:		20151106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eleven Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				252025616
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36296
		FILM NUMBER:		151210858

	BUSINESS ADDRESS:	
		STREET 1:		215 FIRST STREET
		STREET 2:		SUITE 400
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-871-9911

	MAIL ADDRESS:	
		STREET 1:		215 FIRST STREET
		STREET 2:		SUITE 400
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<FILENAME>q32015form10-q_a.htm
<DESCRIPTION>10-Q/A
<TEXT>
Document 1 - file: q32015form10-q_a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>elevenleaseamendment.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
Document 2 - file: elevenleaseamendment.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>3
<FILENAME>q32015form10-q_aexhibit313.htm
<DESCRIPTION>EXHIBIT 31.3
<TEXT>
Document 3 - file: q32015form10-q_aexhibit313.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.4
<SEQUENCE>4
<FILENAME>q32015form10-q_aexhibit314.htm
<DESCRIPTION>EXHIBIT 31.4
<TEXT>
Document 4 - file: q32015form10-q_aexhibit314.htm

</DOCUMENT>
</SEC-DOCUMENT>